Emplozin M 5/500 Tablet is a dual-action medication used in the management of Type 2 diabetes mellitus. It combines two active ingredients: Empagliflozin, a Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor, and Metformin, a biguanide. These two components work together to help control blood glucose levels in patients with Type 2 diabetes.
Empagliflozin works by inhibiting the SGLT2 protein in the kidneys, which reduces the reabsorption of glucose back into the bloodstream. This leads to increased glucose excretion in the urine, thereby lowering blood sugar levels. On the other hand, Metformin works by improving insulin sensitivity and decreasing the liver's production of glucose. This combination provides an effective means to control blood sugar levels, especially when diet and exercise alone are insufficient.
This medication is generally used in combination with other lifestyle changes, such as a healthy diet and regular physical activity, to achieve optimal glycemic control. It can be taken alone or with other antidiabetic medications as prescribed by a healthcare provider.
Emplozin M 5/500 Tablet may also offer cardiovascular benefits, as Empagliflozin has been shown to reduce the risk of major cardiovascular events in patients with Type 2 diabetes and established cardiovascular disease.